Effect of the TNF- inhibitor adalimumab in patients with recalcitrant sarcoidosis: a prospective observational study using FDG-PET

The Clinical Respiratory Journal, 04/17/2012

In sarcoidosis, treatment with adalimumab can reduce disease activity, as assessed by FDG–PET.

Print Article Summary Cat 2 CME Report